OCULUS INNOVATIVE SCIENCES, INC. Form of Series A Warrants for the Purchase of Shares of Common Stock, Par Value $0.0001 per ShareWarrant Agreement • June 11th, 2009 • Oculus Innovative Sciences, Inc. • Surgical & medical instruments & apparatus • California
THIS CERTIFIES that, for consideration, the receipt and sufficiency of which are hereby acknowledged, and other value received, Dayl Crow (the “Holder”) is entitled to subscribe for, and purchase from, OCULUS INNOVATIVE SCIENCES, INC., a Delaware corporation (the “Company”), upon the terms and conditions set forth herein, at any time or from time to time six months after the date this warrant is issued (the “Initial Exercise Date”) until five years after the Issue Date (the “Exercise Period”), up to an aggregate of 50,000 shares of common stock, par value $0.0001 per share (the “Common Stock”), of the Company. This Warrant is initially exercisable at a price of $1.87 per share, subject to adjustment as described in this Warrant. The term “Exercise Price” shall mean, depending on the context, the initial exercise price (as set forth above) or the adjusted exercise price per share. The Company may, in its sole discretion, reduce the then current Exercise Price to any amount or extend the
AMENDMENT NO. 5 TO LEASELease • June 11th, 2009 • Oculus Innovative Sciences, Inc. • Surgical & medical instruments & apparatus • California
This Amendment No. 5 to Lease (“Amendment”) is made and entered into as of May 18, 2009, by and between RNM Lakeville, LLC, a Delaware limited liability company (successor to RNM Lakeville, L.P.) (“Landlord”), and Oculus Innovative Sciences, Inc. (f/k/a MicroMed Laboratories, Inc.), a California corporation (“Tenant”).
CONSULTANT AGREEMENTConsultant Agreement • June 11th, 2009 • Oculus Innovative Sciences, Inc. • Surgical & medical instruments & apparatus • California
THIS AGREEMENT (the “Agreement”) effective April 1, 2009, (hereinafter “Effective Date”) by and between OCULUS INNOVATIVE SCIENCES INC., with a place of business located at 1135 N. McDowell Blvd., Petaluma CA 94954 (hereinafter “Oculus”), a Delaware Corporation and Robert C. Burlingame, with a place of business located at 3546 N. Riverside Avenue, Rialto, California 92377 (hereinafter “Consultant”).
Oculus and Advocos Microcyn U.S. Commercial Launch AgreementCommercial Launch Agreement • June 11th, 2009 • Oculus Innovative Sciences, Inc. • Surgical & medical instruments & apparatus • Delaware
Advocos is in the business of providing outsourcing solutions that are tailored to meet the unique needs of our partners in return for an agreed professional fee and bonus.
